title: FDA regulation of stem-cell-based therapies.
authors.affiliation: School of Medicine, University of California at San Francisco, San Francisco, USA.
authors.forename: Dina Gould
authors.initials: DG
authors.lastname: Halme
authors.forename: David A
authors.initials: DA
authors.lastname: Kessler
mesh_terms: D001688:Biological Products / Q000627:therapeutic use; D033041:Embryo Research / Q000331:legislation & jurisprudence; D004622:Embryo, Mammalian / Q000166:cytology; D015316:Genetic Therapy / Q000331:legislation & jurisprudence; D033161:Government Regulation; D006801:Humans; D007883:Legislation, Medical; D033581:Stem Cell Transplantation / Q000331:legislation & jurisprudence*; D013234:Stem Cells; D014019:Tissue Donors / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D001688:Biological Products